Form 4: U.S. Physical Therapy CFO Carey Hendrickson Reports Changes in Beneficial Ownership
SEC Form 4
Carey Hendrickson, CFO of U.S. Physical Therapy, reports the acquisition of 8,100 shares of common stock and amended vesting terms for outstanding awards.
Summary
- Carey Hendrickson, the CFO of U.S. Physical Therapy, filed a Form 4 detailing changes in beneficial ownership.
- On February 24, 2025, Hendrickson acquired 8,100 shares of common stock as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan.
- These restricted shares vest in 15 equal quarterly installments, starting May 20, 2025, and continuing through March 6, 2029, contingent upon continued employment.
- The vesting terms of 9,838 outstanding unvested shares were amended on February 24, 2025, with revised vesting dates spanning from May 20, 2025, to March 6, 2028.
- Following the reported transactions, Hendrickson beneficially owns 28,569 shares of common stock, including the newly granted and previously held shares.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating alignment of management and shareholder interests. The sentiment is neutral to slightly positive.
Positives
- The grant of restricted stock to the CFO aligns his interests with those of the shareholders.
- The vesting schedule incentivizes continued employment and contribution to the company's success.
Risks
- The vesting of the restricted stock is contingent upon continued employment, creating a potential risk if the CFO were to leave the company before all shares vest.
Future Outlook
The document outlines the vesting schedule for restricted stock and amended shares, indicating the CFO's continued involvement with the company through March 6, 2029, contingent upon employment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's acquisition of shares and adjustments to existing equity awards, which is common practice for aligning management incentives with shareholder value.
Stakeholder Impact
- The vesting schedule incentivizes the CFO to remain with the company, which benefits shareholders, employees, and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 2003 | Amended and Restated 2003 Stock Incentive Plan |
| 02/24/2025 | Date of earliest transaction and amendment of vesting terms |
| 02/26/2025 | Date of signature |
| 05/20/2025 | First vesting date for restricted stock and amended shares |
| 08/20/2025 | Second vesting date for amended shares |
| 11/20/2025 | Third vesting date for amended shares |
| 03/06/2026 | Fourth vesting date for amended shares |
| 05/20/2026 | Fifth vesting date for amended shares |
| 08/20/2026 | Sixth vesting date for amended shares |
| 11/20/2026 | Seventh vesting date for amended shares |
| 03/06/2027 | Eighth vesting date for amended shares |
| 05/20/2027 | Ninth vesting date for amended shares |
| 08/20/2027 | Tenth vesting date for amended shares |
| 11/20/2027 | Eleventh vesting date for amended shares |
| 03/06/2028 | Twelfth vesting date for amended shares |
| 03/06/2029 | Final vesting date for restricted stock |
Keywords
beneficial ownership, Form 4, restricted stock, vesting, CFO, USPH, U.S. Physical Therapy, Hendrickson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.